A proposal for financing postmarketing drug safety studies by augmenting FDA user fees
{{output}}
I propose to raise funds for postapproval studies of long-term drug safety by augmenting the existing "user-fee" system. Fees would be raised by an amount deemed optimal for revenue collection, and the U.S. Food and Drug Administration (FDA) would direct the i... ...
